Haemonetics Corporation (HAE)

Financial leverage ratio

Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Total assets US$ in thousands 2,450,950 2,195,590 1,934,820 1,859,730 1,819,920
Total stockholders’ equity US$ in thousands 820,836 959,959 817,997 749,424 731,670
Financial leverage ratio 2.99 2.29 2.37 2.48 2.49

March 31, 2025 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,450,950K ÷ $820,836K
= 2.99

The financial leverage ratio of Haemonetics Corporation has shown a slight decline over the past few years, from 2.49 in 2021 to 2.29 in 2024. This indicates that the company's reliance on debt to finance its operations has been decreasing. However, it is worth noting that the ratio is not available for 2025, possibly indicating a lack of data for that year. Overall, the decreasing trend in the financial leverage ratio suggests that Haemonetics Corporation is managing its debt levels effectively and becoming less leveraged over time.